These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 4031030)

  • 1. Simplified bioassay method for measurement of flucytosine or ketoconazole.
    Bodet CA; Jorgensen JH; Drutz DJ
    J Clin Microbiol; 1985 Aug; 22(2):157-60. PubMed ID: 4031030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid, simple bioassay for 5-fluorocytosine in the presence of amphotericin B.
    Kaspar RL; Drutz DJ
    Antimicrob Agents Chemother; 1975 Apr; 7(4):462-5. PubMed ID: 1096801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitive bioassay for ketoconazole in serum and cerebrospinal fluid.
    Jorgensen JH; Alexander GA; Graybill JR; Drutz DJ
    Antimicrob Agents Chemother; 1981 Jul; 20(1):59-62. PubMed ID: 6269483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simple assay for 5-fluorocytosine in the presence of amphotericin B.
    Kauffman CA; Carleton JA; Frame PT
    Antimicrob Agents Chemother; 1976 Mar; 9(3):381-3. PubMed ID: 769677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multisite reproducibility of the Etest MIC method for antifungal susceptibility testing of yeast isolates.
    Pfaller MA; Messer SA; Bolmström A; Odds FC; Rex JH
    J Clin Microbiol; 1996 Jul; 34(7):1691-3. PubMed ID: 8784571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of serum 5-fluorocytosine concentrations in the presence of ketoconazole.
    Roselle GA; Warth P
    J Antimicrob Chemother; 1983 Aug; 12(2):189-92. PubMed ID: 6311787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro antifungal susceptibility of Candida.
    Chakrabarti A; Ghosh A; Kanta A; Kumar P
    Indian J Med Res; 1995 Jul; 102():13-9. PubMed ID: 7558204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relapse of Candida parapsilosis endocarditis after long-term suppression with flucytosin: retreatment with valve replacement and ketoconazole.
    Samelson LE; Lerner SA; Resnekov L; Anagnostopoulos C
    Ann Intern Med; 1980 Dec; 93(6):838-9. PubMed ID: 6255847
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination of oral flucytosine and ketoconazole as therapy for experimental cryptococcal meningitis.
    Craven PC; Graybill JR
    J Infect Dis; 1984 Apr; 149(4):584-90. PubMed ID: 6327836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro susceptibilities of sucrose-negative Candida tropicalis, Candida lusitaniae, and Candida norvegensis to amphotericin B, 5-fluorocytosine, miconazole, and ketoconazole.
    Ahearn DG; McGlohn MS
    J Clin Microbiol; 1984 Mar; 19(3):412-6. PubMed ID: 6325491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro.
    Odds FC
    Antimicrob Agents Chemother; 1982 Nov; 22(5):763-70. PubMed ID: 6295266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid enzymatic method for measurement of serum flucytosine levels.
    Washburn RG; Klym DM; Kroll MH; Bennett JE
    J Antimicrob Chemother; 1986 May; 17(5):673-7. PubMed ID: 3522527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microtiter broth dilution method for yeast susceptibility testing with validation by clinical outcome.
    Radetsky M; Wheeler RC; Roe MH; Todd JK
    J Clin Microbiol; 1986 Oct; 24(4):600-6. PubMed ID: 3771749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of experimental cryptococcal meningitis with amphotericin B, 5-fluorocytosine, and ketoconazole.
    Perfect JR; Durack DT
    J Infect Dis; 1982 Sep; 146(3):429-35. PubMed ID: 6286799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of a survey of antifungal susceptibility tests in the United States and interlaboratory comparison of broth dilution testing of flucytosine and amphotericin B.
    Calhoun DL; Roberts GD; Galgiani JN; Bennett JE; Feingold DS; Jorgensen J; Kobayashi GS; Shadomy S
    J Clin Microbiol; 1986 Feb; 23(2):298-301. PubMed ID: 3517051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of high-performance liquid chromatography and bioassay for the determination of 5-fluorocytosine in serum.
    Hülsewede JW
    Zentralbl Bakteriol; 1994 Nov; 281(4):513-8. PubMed ID: 7727899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of medium composition on results of macrobroth dilution antifungal susceptibility testing of yeasts.
    Doern GV; Tubert TA; Chapin K; Rinaldi MG
    J Clin Microbiol; 1986 Oct; 24(4):507-11. PubMed ID: 3533974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of incubation temperature, inoculum size, and medium on agreement of macro- and microdilution broth susceptibility test results for yeasts.
    Cook RA; McIntyre KA; Galgiani JN
    Antimicrob Agents Chemother; 1990 Aug; 34(8):1542-5. PubMed ID: 2221863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of pH and buffer effects on flucytosine activity in broth dilution susceptibility testing of Candida albicans in two synthetic media.
    Calhoun DL; Galgiani JN
    Antimicrob Agents Chemother; 1984 Sep; 26(3):364-7. PubMed ID: 6391370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole.
    Martín E; Parras P; Lozano MC
    Chemotherapy; 1992; 38(5):335-9. PubMed ID: 1337508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.